ImmuCell
ICCC
ICCC
13 hedge funds and large institutions have $939K invested in ImmuCell in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.
Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$114K |
| 2 |
U
2
UBS
Zurich,
Switzerland
|
$7K |
| 3 |
SKK
3
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
$130K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
HP
1
HealthInvest Partners
Stockholm,
Sweden
| $297K | 69,608 | +69,608 | New |
|
|
SRC
2
Shufro Rose & Co
New York
| $221K | 51,863 | – | – |
|
|
SKK
3
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| $130K | 30,467 | -826 | -3% |
|
|
4
Morgan Stanley
New York
| $114K | 26,834 | -3,252 | -11% |
|
|
EFS
5
Essex Financial Services
Essex,
Connecticut
| $101K | 23,776 | – | – |
|
6
Renaissance Technologies
New York
| $53K | 12,400 | +1,400 | +13% |
|
7
Bank of America
Charlotte,
North Carolina
| $9K | 2,036 | +4 | +0.2% |
|
|
U
8
UBS
Zurich,
Switzerland
| $7K | 1,697 | -1,625 | -49% |
|
|
TDC
9
Thompson Davis & Co
Richmond,
Virginia
| $3K | 750 | +750 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $3K | 783 | +783 | New |
|
11
Creative Planning
Overland Park,
Kansas
| $1K | 310 | – | – |
|
12
Wells Fargo
San Francisco,
California
| $0 | 1 | – | – |
|
13
US Bancorp
Minneapolis,
Minnesota
| $0 | 24 | – | – |
|